Gilead Sciences (GILD)
$110.46
1.07 (0.96%)
GILD Stock Quote Delayed 30 Minutes
Dow Jones Today: Vaccine Hopes Overcame Contracting GDP
The remdesivir news took precedent over headlines about first-quarter GDP, which contracted 4.8%, or the worst shrinkage experienced by the world's largest economy since the dark days of the global financial crisis.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
138.50B
PE Ratio
1,380.75
EPS
0.08
Volume (Avg. Vol.)
5.91M
Day's Range
$108.40 - $111.07
52-Week Range
$62.07 - $112.11
Dividend & Yield
$3.08 (2.79%)
GILD Stock Predictions, Articles, and Gilead Sciences News
Stock Market Today: Small-Cap Stocks Roar to Life; GM Cuts Dividend
GM is cutting its dividend and Apple is delaying iPhone production. Here's what happened in the stock market today.
Don’t Let Negative Data Dissuade You from Gilead Sciences
Late last week, a Financial Times report suggested that Gilead’s coronavirus candidate drug remdesivir was not effective. However, the narrative for GILD stock requires a much broader context.
7 Beautiful Biotech Stocks to Buy Here
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
Why Remdesivir Clinical Studies Will Lift Gilead Sciences
GILD stock rose sharply in recent weeks as markets bet the company has a treatment against the novel coronavirus.
5 Top Stock Trades for Friday: GILD, INO, LVS, DPZ, LLY
Eli Lilly, Domino's Pizza, Gilead Sciences, Las Vegas Sands and Inovio Pharmaceuticals were our top stock trades for Friday.
Stock Market Today: Gilead Hit; Zoom’s Major Growth
More than 26.3 million Americans have filed for unemployment benefits in the past five weeks. Here's the stock market today.
Buy the Dip in Gilead Stock Because Remdesivir May Not Be a Flop
A report that Gilead's Covid-19 treatment, remdesivir, flopped in clinical trials is misleading, and the dip in GILD stock is an opportunity.
Stock Market Today: Oil Prices Plunge and Go Negative
Front-month oil futures plunged into negative territory in the stock market today. Here's the scoop on what's going on.
Stock Market Today: Berkshire’s Munger Opens Up; Sell Apple?
We saw equities jump to life in the stock market today, as investors hope for a cure for the coronavirus. Here's what happened on Friday.
Gilead Stock Isn’t Worth Chasing Now Despite Recent Remdesivir Success
Gilead's remdesivir appears to be an effective treatment against the coronavirus. Still, I wouldn't chase GILD stock now.
Stock Market Today: Apple’s New iPhone; Abbott’s New Coronavirus Test
Apple launched a new iPhone, while the earnings reports continue to trickle in. Here's what happened in the stock market today.
Buying Gilead Sciences Stock Means Buying Into Political Risk
GILD stock is rising on Gilead's potential coronavirus cure. But Gilead also has a questionable past, and it faces worrying patent disputes.
Initial Coronavirus Treatment Trials Look Good for Gilead Stock
GILD stock is getting a boost from early trials of its remdesivir drug, which is showing some promise in treating the novel coronavirus.
Gilead Stock Could Get a Lift From a Coronavirus Treatment
Gilead delivered some good news on a remdesivir trial, That's positive news for GILD stock and the owners of the shares.
Good News for Remdesivir Is Good News for Gilead Sciences Stock
Lately there have been more indications that Gilead's drug will become a key treatment for the coronavirus. That's positive for GILD stock.
Gilead Sciences Pins Its Hopes on Remdesivir
Clinical trial results for Gilead's remdesivir should come this month. If it's effective, GILD stock could explode higher on the news.
Stock Market Today: Major Indices Roar Back to Life; Buy Tesla?
JPMorgan's Jamie Dimon gave his thoughts on the current pandemic, as Immunomedics shares double. Here's the stock market today.
Immunomedics News: IMMU Stock Rockets on Promising Breast Cancer Drug
Immunomedics news has IMMU stock soaring on Monday after its breast cancer treatment drug study was halted due to "evidence of efficacy."
